title: Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.
abstract: Previous attempts to use ultrasound (less than or equal to 1-MHz frequency and 1 to 3-W/cm2 intensity) to enhance transdermal drug delivery (so-called sonophoresis) have produced inconsistent results. Theoretical analysis of ultrasound propagation in tissue predicts that higher-frequency ultrasound (greater than 1 MHz) will increase the concentration of energy deposition in the stratum corneum (SC) (typically, the rate-limiting barrier to percutaneous penetration). This hypothesis was tested by comparing the passive transdermal delivery of salicylic acid with that under the influence of ultrasound at 2-, 10-, and 16-MHz frequency; measurements were performed in vivo in hairless guinea pigs. Total drug absorbed was quantified by determining the amount of salicylic acid (1) present in SC tape strips and (2) eliminated in urine. Sonophoresis for 20 min at 2 MHz caused no significant increase in salicylic acid delivery over passive diffusion; treatment with ultrasound at 10 and 16 MHz, on the other hand, significantly elevated salicylic acid transport, by 4-fold and 2.5-fold, respectively. Kinetic analysis of the sonophoretic data at 10 and 16 MHz also revealed that the diffusion lag time associated with transdermal drug delivery (TDD) was reduced. A shorter period (5 min) of sonophoresis again resulted in enhanced TDD (relative to the corresponding control) at the higher frequencies; the delivered dose, and the level of enhancement, however, were lower than those after the 20-min treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Graduate Group in Bioengineering, University of California, Berkeley.
authors.forename: D
authors.initials: D
authors.lastname: Bommannan
authors.forename: H
authors.initials: H
authors.lastname: Okuyama
authors.forename: P
authors.initials: P
authors.lastname: Stauffer
authors.forename: R H
authors.initials: RH
authors.lastname: Guy
mesh_terms: D000818:Animals; D002250:Carbon Radioisotopes; D016503:Drug Delivery Systems; D005782:Gels; D006168:Guinea Pigs; D012459:Salicylates / Q000493:pharmacokinetics / Q000652:urine; D020156:Salicylic Acid; D012869:Skin Absorption / Q000502:physiology*; D014465:Ultrasonics
chemical_list: D002250:Carbon Radioisotopes; D005782:Gels; D012459:Salicylates; D020156:Salicylic Acid